Stanford University
Showing 1,181-1,190 of 1,552 Results
-
Rebecca Saenz
Clinical Assistant Professor, Pediatrics - Immunology
Current Research and Scholarly InterestsAllergy, Immunology, Bioengineering and Biodesign
-
Julien Sage
Elaine and John Chambers Professor of Pediatric Cancer and Professor of Genetics
Current Research and Scholarly InterestsWe investigate the mechanisms by which normal cells become tumor cells, and we combine genetics, genomics, and proteomics approaches to investigate the differences between the proliferative response in response to injury and the hyperproliferative phenotype of cancer cells and to identify novel therapeutic targets in cancer cells.
-
Neetu Saini
Postdoctoral Scholar, Stem Cell Transplantation
BioMy research interests focus on translational human T-cell immunology, with an emphasis on regulatory T cells (Tregs) and their therapeutic potential in restoring immune tolerance and tissue homeostasis. I am particularly interested in engineering FOXP3-programmed CD4⁺ T cells as a stable and functional alternative to conventional Tregs, especially in inflammatory settings where endogenous Tregs may be unstable or dysfunctional. My work integrates gene-editing approaches, immunophenotyping, and human organoid systems to study how these engineered cells interact with epithelial and stem cell compartments, with a focus on mechanisms of tissue repair and immune–epithelial crosstalk in barrier tissues such as the intestine. Moving forward, I aim to advance next-generation cell therapies by combining insights from T-cell biology, tissue biology, and disease modeling to develop durable and clinically relevant strategies for treating immune-mediated and epithelial barrier disorders.
-
Debbie C. Sakaguchi Sakai
Clinical Professor, Pediatrics
Current Research and Scholarly InterestsMedical education, shared decision making, resuscitation.
-
Kathleen M. Sakamoto
Shelagh Galligan Professor in the School of Medicine
Current Research and Scholarly InterestsMy research focuses on the molecular pathways that regulate normal and aberrant blood cell development, including acute leukemia and bone marrow failure syndromes. We are also studying novel drugs for treatment of cancer.
